Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Baxter's DCLHb safe in acute ischemic stroke patients

June 27, 1997

Phase II results with Immunex's Flt3 ligand reported

June 27, 1997

Kyowa Hakko discloses new calcitonin derivatives

June 27, 1997

Hypolipidemic effects of F-1394 in hyperlipidemic dogs

June 26, 1997

Potential new antidiabetic and antiobesity agent from Dainippon

June 26, 1997

Positive efficacy profile for MacroChem's erectile dysfunction therapy

June 26, 1997

Encouraging data reported for Sugen's insulin phosphatase inhibitors

June 26, 1997

Kyowa Hakko claims compounds for thrombocytopenia

June 26, 1997

Amylin and J&J expand product development program

June 25, 1997

Update on clinical progression of Amylin's diabetes drug

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...